MUNG Legal Showcased 150.Ventures at BIOHK 2025: Blockchain Meets Biopharma for Human Longevity

From September 10–13, 2025, MUNG Legal proudly presented its latest innovation, 150.Ventures, at BIOHK 2025 in Hong Kong—one of the world’s most influential biotechnology and life science conventions. The initiative captured significant attention across investors, scientists, and innovators, highlighting how blockchain and RWA (Real-World Assets) can redefine the future of longevity research.

MUNG Legal: Leading Blockchain Law Across Asia

As the first blockchain-focused law firm in Hong Kong and much of Southeast Asia, MUNG Legal has been at the forefront of blockchain law and compliance for nearly a decade, in 2024, we have even successfully litigated and won the world’s first DAO case. With offices in Hong Kong, Singapore, and mainland China and partnerships and joint-ventures all across the globe, MUNG has successfully structured projects ranging from:

• Dubai luxury real estate RWAs that generated rental income through tokenization

• Durian farm RWAs that attracted niche agricultural investors

• Biomedical RWAs positioned as long-term growth capital

  
  

At BIOHK 2025, MUNG extended this expertise to the life sciences, showing how blockchain legal frameworks can provide transparency, efficiency, and security for biomedical innovation.

Longevity: A Growing Market

BIOHK 2025 highlighted why longevity is one of the fastest-growing frontiers:

• $85 billion global market size in 2025

• $120 billion projected by 2030 (7.08% CAGR)

• Asia, especially China and Southeast Asia, emerging as key hubs for wellness and health consumption

Yet, the industry continues to face barriers like fragmented research, limited early-stage funding, and lack of transparency—issues that 150.Ventures directly addresses.

Introducing 150.Ventures

150.Ventures, introduced at BIOHK 2025, is a DAO-based RWA platform dedicated to longevity and life science ventures. Its mission is clear: to support research and projects that can extend human lifespans to 150 years.

Key features include:

• DAO Governance: Token holders vote on funding decisions and research priorities.

• RWA Tokenization: Investments in real-world longevity projects are tokenized, making them secure and globally accessible.

• Expert Collaboration: Supported by leading scientists and healthcare innovators, ensuring funds go where they matter most.

Blockchain + Biopharma: Insights from BIOHK 2025

During the event, MUNG Legal emphasized how blockchain is transforming the biomedical sector:

• Traceability & Anti-Counterfeit: Ensuring drug supply chains and clinical trial data remain tamper-proof.

• Financing Innovation & Transparency: Using RWA tokenization to raise global capital faster and more efficiently for biotech projects. Providing unparalleled transparency to the investors.

• Intellectual Property: Turning patents and R&D outcomes into NFTs, and other RWA assets, accelerating commercialization and licensing.

  
  

By combining blockchain flexibility with scientific rigor, 150.Ventures offers a novel investment model where innovation and compliance go hand-in-hand.

Looking Ahead

MUNG Legal’s presence at BIOHK 2025 reinforced its role as a bridge between blockchain and biopharma, helping innovators link with global capital and communities in a compliant, transparent way.

150.Ventures is now building its community of early DAO members and investors, paving the way for the next generation of life science breakthroughs.

As we continue this journey, MUNG Legal invites collaborators, researchers, and investors who believe Web3.0 can reshape the real economy to join us in defining the next era of longevity innovation.